MEF2C and acute myeloid leukemia: Recent studies have also shown that MEF2C plays an important role in myocilin mediating cancer-induced muscle wasting and cachexia in cancer patients [32] and regulates chemotherapeutic resistance [33] and the disease progression of acute myeloid leukemia [34].